Opportunity
NY Office of State Comptroller #X036871
Award for WIC Soy-Based Infant Formula Rebate to Abbott Laboratories
Posted
September 17, 2021
Identifier
X036871
NAICS
325414
This award notice details the selection of Abbott Laboratories by the New York Department of Health for the WIC program's soy-based infant formula rebate contract. - Government Buyer: - New York Department of Health - OEM Highlight: - Abbott Laboratories is the sole Original Equipment Manufacturer (OEM) and vendor named - Products/Services Requested: - Rebate for soy-based infant formula products under the WIC program - No specific part numbers or quantities provided - Contract Details: - Initial contract value: approximately $21.35 million - Final amended value: $15,253,743 - Revenue-generating contract related to medical/pharmacy services - Notable Requirements: - Focused on rebate structure for soy-based infant formula - No unique technical or operational requirements specified beyond standard rebate provisions
Description
This contract is for the rebate of soy-based infant formula under the Women, Infants, and Children (WIC) program. The original contract amount was approximately $21.35 million, with a subsequent amendment reducing the total by approximately $6.1 million. The contract is revenue-generating and related to medical/pharmacy services. The period of performance is from October 1, 2021 to September 30, 2026. The contract is awarded by the Department of Health in New York, US.